This company listing is no longer active
2118 Stock Overview
Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥0.37 |
| 52 Week High | CN¥2.98 |
| 52 Week Low | CN¥0.37 |
| Beta | 0.46 |
| 1 Month Change | 0% |
| 3 Month Change | -76.88% |
| 1 Year Change | -85.43% |
| 3 Year Change | -92.04% |
| 5 Year Change | -93.32% |
| Change since IPO | -73.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2118 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -4.9% |
| 1Y | -85.4% | -19.0% | -21.1% |
Return vs Industry: 002118 underperformed the CN Pharmaceuticals industry which returned -1.6% over the past year.
Return vs Market: 002118 underperformed the CN Market which returned -4.4% over the past year.
Price Volatility
| 2118 volatility | |
|---|---|
| 2118 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.4% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 002118's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 002118's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 842 | Youshun Feng | www.jilinzixin.com.cn |
Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China. It provides ginseng drugs, prescription drugs, and OTC drugs. The company offers its products in the form of pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, and lozenges.
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Fundamentals Summary
| 2118 fundamental statistics | |
|---|---|
| Market cap | CN¥473.88m |
| Earnings (TTM) | -CN¥1.19b |
| Revenue (TTM) | CN¥149.92m |
3.2x
P/S Ratio-0.4x
P/E RatioIs 2118 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2118 income statement (TTM) | |
|---|---|
| Revenue | CN¥149.92m |
| Cost of Revenue | CN¥63.88m |
| Gross Profit | CN¥86.04m |
| Other Expenses | CN¥1.28b |
| Earnings | -CN¥1.19b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 23, 2023
| Earnings per share (EPS) | -0.93 |
| Gross Margin | 57.39% |
| Net Profit Margin | -793.41% |
| Debt/Equity Ratio | 497.1% |
How did 2118 perform over the long term?
See historical performance and comparison